Characterization of combined linagliptin and Y2R agonist treatment in diet-induced obese mice
2021 · Scientific Reports · 13 citations
https://doi.org/10.1038/s41598-021-87539-7
T
Tamara Baader-Pagler
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
201
Citations
6
h-index
5
i10-index
Tamara Baader-Pagler is an academic researcher from Boehringer Ingelheim (Germany). The author has contributed to research in topics: Diabetes Treatment and Management & Regulation of Appetite and Obesity & Neuropeptides and Animal Physiology. The author has an h-index of 6, co-authored 8 publications.
Papers by this author
worksThe calcitonin receptor is the main mediator of LAAMA's body weight lowering effects in male mice
2021 · European Journal of Pharmacology · 8 citations
https://doi.org/10.1016/j.ejphar.2021.174352
Development of Petrelintide: a Potent, Stable, Long-Acting Human Amylin Analogue
2025 · Journal of Medicinal Chemistry · 5 citations
https://doi.org/10.1021/acs.jmedchem.5c01185
Novel NPY2R agonist BI 1820237 provides synergistic anti-obesity efficacy when combined with the GCGR/GLP-1R dual agonist survodutide
2025 · Molecular Metabolism · 1 citations
https://doi.org/10.1016/j.molmet.2025.102205
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat